Alpha Teknova Inc (TKNO) Actualités

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Teknova Reports Fourth Quarter and Full Year 2024 Financial Results

Full year 2024 total revenue was $37.7 million, up 3% year-over-year and in line with guidanceFourth quarter...

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Teknova Reports Third Quarter 2024 Financial Results

Third quarter 2024 total revenue was $9.6 million, up 17% over the same quarter prior yearCompany lowers 2024...

Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024

HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Teknova Reports Second Quarter 2024 Financial Results

Second quarter 2024 total revenue was $9.6 million, up 3% sequentiallyRaised $15.4 million of equity capital in...

Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development

Express-TekSM Production enables customers to have their products enter production in days instead of weeks...